[Corrigendum] BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor

Yu,Jing; Chen,Ling; Bao,Zhenhua; Liu,Ying; Liu,Guohong; Li,Fengling; Li,Lianqin

doi:10.3892/or.2022.8352

August-2022 Volume 48 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August-2022 Volume 48 Issue 2

Full Size Image

Correction Open Access

[Corrigendum] BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor

Authors:
- Jing Yu
- Ling Chen
- Zhenhua Bao
- Ying Liu
- Guohong Liu
- Fengling Li
- Lianqin Li
View Affiliations / Copyright

Affiliations: Department of Pathology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, P.R. China, Department of Obstetrics and Gynecology, First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang 832001, P.R. China, Department of Oncology, People's Hospital of Haiyang, Haiyang, Shandong 265100, P.R. China, Department of Physical Examination, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, P.R. China, Department of Obstetrics and Gynecology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, P.R. China

Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 141
|
Published online on: June 20, 2022

https://doi.org/10.3892/or.2022.8352
Expand metrics +

Article

Oncol Rep 43: [Related article:] 1630–1640, 2020; DOI: 10.3892/or.2020.7539

Following the publication of the above paper, an interested reader drew to the authors’ attention that, in Fig. 5 on p. 1637, the data panel selected to represent the ‘Ishikawa/+BMI-1 siRNA/Invasion’ experiment in Fig. 5A appeared to overlap with the data shown for the ‘JEC/+BMI-1 siRNA/Migration’ panel in Fig. 5C, such that they were potentially derived from the same original source.

Figure 5.

Effect of BMI-1 on migration and invasion of endometrial adenocarcinoma cells. (A) Representative images and (B) quantitative analysis of migration and invasion in Ishikawa cells. (C) Representative images and (D) quantitative analysis of migration and invasion in JEC cells. Magnification, ×200. ***P<0.01. BMI-1, B-lymphoma Mo-MLV insertion region 1; si-RNA, small interfering RNA; NC, negative control.

The authors have re-examined their original data, and realize that the data panel selected for the ‘Ishikawa/+BMI-1 siRNA/Invasion’ experiment in Fig. 5A was inadvertently selected incorrectly. The corrected version of Fig. 5, showing the correct data for the ‘Ishikawa/+BMI-1 siRNA/Invasion’ experiment in Fig. 5A, is shown below. Note that this error did not affect the overall conclusions reported in the study. The authors are grateful to the Editor of Oncology Reports for granting them the opportunity to publish this Corrigendum; furthermore, they apologize for any inconvenience caused to the readership of the Journal.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor

This article is mentioned in:

Article

Figure 5.

Related Articles